Mete Yaşar

Ustekinumab Treatment Persistence in Ulcerative Colitis Patients Unresponsive to Biologic Treatment: A Single-Center Real-World Experience

Ustekinumab is an effective biological agent for the treatment of ulcerative colitis (UC); however, real-world data on treatment persistence and factors affecting drug survival in biologic-experienced patients remain limited. This retrospective cohort study aimed to evaluate uste...